Biopharma | January 01, 2026
Savara resubmits FDA application for potential treatment in rare lung disease patients
The resubmission of BLA for MOLBREEVI names Fujifilm as the drug substance manufacturer
The resubmission of BLA for MOLBREEVI names Fujifilm as the drug substance manufacturer
VitiPure serves as essential solubilizers, emulsifiers, and bioavailability enhancers in drug formulations
This new suite of products demonstrates Nouryon’s leadership in cleaning ingredient solutions
Ultra-high purity surfactant for biologics and parenteral drug formulations
DKSH has further fortified its strategic partnership with Biolin Scientific, a globally recognized pioneer in surface science instrumentation, across nine key markets in the APAC region
UTD2 is the world's first oral epothilone microtubule inhibitor
The new plant at Slovenská ?up?a site in Slovakia is scheduled to come on stream in two years
Subscribe To Our Newsletter & Stay Updated
